Summary
The present study examined the regional vascular effects (radioactive microspheres) of converting-enzyme inhibition (captopril, 1mg/kg) and calcium-antagonism (diltiazem, 1 mg/kg) in a rat model of cardiac failure due to large myocardial infarction (n=18, infarct size 40% of the left ventricle) both at rest and during submaximal tread-mill exercise. Diltiazem increased renal, gastrointestinal, coronary and cutaneous blood flow at rest by 29%, 28%, 26% and 37% (p<0.05 each) and enhanced skeletal muscle blood flow during exercise by 16% (p<0.05). Captopril improved primarily renal and coronary blood flow at rest (by 59% and 23%, respectively,p<0.05) and reduced vascular resistance in the gastrointestinal bed by 25% (p<0.05) without significant effects in other circulatory beds. We conclude that the regional vascular effects elicited by converting-enzyme inhibition and calcium antagonism differ considerably in this animal model of congestive heart failure and may be clinically important. The favourable regional vascular profile of diltiazem deserves further clinical investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literatur
Carlyle PF, Cohn JN (1983) A nonsurgical canine model of chronic left ventricular myocardial dysfunction. Am J Physiol 244:H769–774
Craeger MA, Halperin JL, Bernard DB, Faxon DP, Meldidossian CD, Gavras H, Ryan TJ (1981) Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circ 64:483–489
Drexler H, Fields RH, Toggart EJ, Flaim SF (1982) Nisoldipine i.v. improves skeletal muscle blood flow at rest and during exercise. Circ 66 (suppl II):II-141
Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat. Am J Pathol 90:57–66
Flaim SF, Annibali JA, Newman ED, Zelis R (1982a) Effects of diltiazem on the cardiocirculatory response to exercise in conscious rat. J Pharmacol Exp Ther 223:624–630
Flaim SF, Kanda K (1982b) Comparative pharmacology of calcium blockers based on studies of cardiac output distribution. In: Flaim SF, Zelis R (eds) Calcium blockers; Urban and Schwarzenberg, Baltimore München, pp 179–192
Flaim SF, Nellis SH, Toggart EJ, Drexler H, Kanda K, Newman ED (1984) Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rat. J Pharmacol Methods 11:1–39
Gavras H, Liang C, Brunner HR (1978) Redistribution of regional blood flow after inhibition of the angiotensin-converting enzyme. Circ Res 43:159–163
Heymann MA, Payne BD, Hoffman JIE, Rudolph AM (1977) Blood flow measurements with radionuclide-labelled particles. Prog Cardiovasc Dis 20:55–79
Hodsmann GP, Robertson JIS (1983) Captopril: five years on. Br Med J 287:851–852
Ishikawa H, Matsushima M, Matsui H, Honjo A, Hayashi M, Marifuji T, Okabayashi M (1978a) Effects of diltiazem hydrochloride (CRD-401) on renal hemodynamics of dogs. Arzneim.-Forsch./Drug Res. 28:402–406
Ishikawa H, Matsushima A, Matsui H, Shindo T, Morifuji T, Okabayashi M (1978b) Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric, and femoral hemodynamics. Arzneimittelforsch 28:400–402
Ito Y, Kuriyama H, Suzuki H (1978) The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit. Br J Pharmacol 64:503–510
Knight DR, Vatner SF (1984) Effects of calcium channel blokkers on blood flow distribution in conscious dogs. JACC 3:499
Kugler J, Maskin C, Frishman WH, Sonnenblick EH, LeJemtel TH (1982) Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure. Circ 66:1256–1261
Massie BM, Chatterjee K, Parmley WW (1979) Vasodilator therapy for acute and chronic heart failure. In Yu PN, Goodwin J (eds) Progress in Cardiology. Vol 8, Lea & Febiger, Philadelphia, pp 197–235
Packer M (1983) Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. J Am Coll Cardiol 2:841–852
Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503–512
Powers ER, Bannerman KS, Stone J, Reison DS, Escala EL, Kalischer A, Weiss MB, Sciacca RR, Cannon PJ (1982) The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure. Am Heart J 104:1203–1210
Riecker G (1983) Kardiologie, Langzeittherapie der chronischen Herzinsuffizienz. Münch med Wschr 125:607–609
Rouleau J, Chatterjee K, Benge W, Parmley WW, Hiramatsu B (1982) Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circ 65:671–678
Watkins L, Burton JA, Haber E, Cant JR, Smith FW, Barger AC (1976) The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57:1606–1617
Wilson JR, Martin JL, Ferraro N, Weber KT (1983) Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure. Circ 68:425–432
Winer BJ (1971) Statistical principles in experimental design. McGraw Hill, New York
Zelis R, Wichman T, Starke K (1982) Inhibition of vascular noradrenaline by diltiazem. Circ 66 (suppl II):II-139
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft Dr 148/2-1
Rights and permissions
About this article
Cite this article
Drexler, H., Truog, A.G., Just, H. et al. Die Beeinflussung der Organperfusion durch Kalziumblocker und Converting-Enzyminhibitor an der herzinsuffizienten, wachen Ratte. Klin Wochenschr 63, 262–267 (1985). https://doi.org/10.1007/BF01731472
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01731472